Immix Biopharma
clinical development plan through submissions light chain | Immix Biopharma
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
23 of 64
Similar slides by Immix Biopharma
See diffirences between slides (animation)
Investor Presentation
January 2024
clinical development plan through submissions | Immix Biopharma
Investor Presentation
December 2023
clinical development plan through submissions | Immix Biopharma
Investor Presentation
November 2023
clinical development plan through submissions light chain | Immix Biopharma
Investor Presentation
November 2023
clinical development plan through submissions light chain | Immix Biopharma
Related slides by other companies
Genprex
Investor Presentation
November 2024
phase dose in relapsed patients | Genprex
BioAtla
Investor Presentation
January 2024
encouraging phase results with cab | BioAtla
Equillium
Investor Presentation
December 2023
clinically validated in severe dermatological disease | Equillium
BioNTech
Results
November 2020
phase a safety profile | BioNTech
Other recent decks by Immix Biopharma
See all presentations (11 decks)
Investor Presentation
March 2024
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights